<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <atom:link href="https://feeds.simplecast.com/6cwg4X41" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>The &quot;PHARMED&quot; Podcast</title>
    <description>Join pharmacist Ajit Johal and physician Christine Palmay as they share their thoughts and expertise on collaborative patient care.   Each episode features an important clinical topic and discussion about &quot;breaking down barriers in primary care&quot; in order to support patients and health care providers!</description>
    <language>en</language>
    <pubDate>Mon, 4 Jul 2022 04:00:00 +0000</pubDate>
    <lastBuildDate>Tue, 5 Jul 2022 02:43:21 +0000</lastBuildDate>
    <image>
      <link>https://the-pharmed-podcast.simplecast.com</link>
      <title>The &quot;PHARMED&quot; Podcast</title>
      <url>https://image.simplecastcdn.com/images/b510a02d-6257-4d75-9109-5d57fdc34339/615f3751-26aa-40ab-8674-4a46e60b2612/3000x3000/printable-resolution-option2-01.jpg?aid=rss_feed</url>
    </image>
    <link>https://the-pharmed-podcast.simplecast.com</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>Join pharmacist Ajit Johal and physician Christine Palmay as they share their thoughts and expertise on collaborative patient care.   Each episode features an important clinical topic and discussion about &quot;breaking down barriers in primary care&quot; in order to support patients and health care providers!</itunes:summary>
    <itunes:author>Christine Palmay, Ajit Johal</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/b510a02d-6257-4d75-9109-5d57fdc34339/615f3751-26aa-40ab-8674-4a46e60b2612/3000x3000/printable-resolution-option2-01.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/6cwg4X41</itunes:new-feed-url>
    <itunes:keywords>collaboration, healthcare, medicine, pharmacy</itunes:keywords>
    <itunes:owner>
      <itunes:name>PHARMED</itunes:name>
      <itunes:email>ajit@travelrx.ca</itunes:email>
    </itunes:owner>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:category text="Education">
      <itunes:category text="How To"/>
    </itunes:category>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">c4f273e9-46e1-43df-ba1e-4174a865d17f</guid>
      <title>Not compromising with vaccine preventable diseases</title>
      <description><![CDATA[<ul><li>The definition of “immunocompromised” is broad, but the following committees provide guidance </li><li><a href="https://urldefense.com/v3/__https:/www.cdc.gov/shingles/vaccination/immunocompromised-adults.html__;!!AoaiBx6H!gTgHbQZwsoIYynTOrWPHjxeWZGodefGO0zpEIKEubXK5k89pjoPOe7QRAww7dXaAVxP3$" target="_blank">ACIP’s updated clinical guidance immunocompromised adults</a> (in relation to shingles)</li><li><a href="https://urldefense.com/v3/__https:/www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html*a8.1.4.1.1__;Iw!!AoaiBx6H!gTgHbQZwsoIYynTOrWPHjxeWZGodefGO0zpEIKEubXK5k89pjoPOe7QRAww7da1mG4lT$" target="_blank">NACI’s definitions of moderately to severely immunocompromised</a> (in relation to COVID-19)</li><li><a href="http://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part4/COVID-19-vaccine-eligibility.pdf">COVID-19-vaccine-eligibility.pdf (bccdc.ca)</a></li></ul><p>•CIQ recommends RZV for <strong>individuals ≥18 years of age </strong>who are immunocompromised or have chronic conditions which increase HZ risk . Ministère de la Santé et des Services sociaux. Available from: https://www.msss.gouv.qc.ca/professionnels/vaccination/piq-vaccins/zona-su-vaccin-sous-unitaire-contre-le-zona/</p><p>Immunocompromised patients often need multiple vaccinations - Please do your best to administer them in a single visit </p><p>•<strong>For adults and adolescents, COVID-19 vaccines may be given simultaneously with (i.e., same day), or at any time before or after, non-COVID-19 vaccines (including live and non-live vaccines)</strong>.</p><p> </p><p><strong>Despite strong uptake of COVID-19 vaccinations, other adult immunizations lag behind - Be sure to address all "Immunization Gaps" for your Clinically Vulnerable Patients </strong></p>
]]></description>
      <pubDate>Mon, 4 Jul 2022 04:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (Christine Palmay, Ajit Johal)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/episode7-not-compromising-with-vaccine-preventable-diseases-vb47mwz_</link>
      <content:encoded><![CDATA[<ul><li>The definition of “immunocompromised” is broad, but the following committees provide guidance </li><li><a href="https://urldefense.com/v3/__https:/www.cdc.gov/shingles/vaccination/immunocompromised-adults.html__;!!AoaiBx6H!gTgHbQZwsoIYynTOrWPHjxeWZGodefGO0zpEIKEubXK5k89pjoPOe7QRAww7dXaAVxP3$" target="_blank">ACIP’s updated clinical guidance immunocompromised adults</a> (in relation to shingles)</li><li><a href="https://urldefense.com/v3/__https:/www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html*a8.1.4.1.1__;Iw!!AoaiBx6H!gTgHbQZwsoIYynTOrWPHjxeWZGodefGO0zpEIKEubXK5k89pjoPOe7QRAww7da1mG4lT$" target="_blank">NACI’s definitions of moderately to severely immunocompromised</a> (in relation to COVID-19)</li><li><a href="http://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part4/COVID-19-vaccine-eligibility.pdf">COVID-19-vaccine-eligibility.pdf (bccdc.ca)</a></li></ul><p>•CIQ recommends RZV for <strong>individuals ≥18 years of age </strong>who are immunocompromised or have chronic conditions which increase HZ risk . Ministère de la Santé et des Services sociaux. Available from: https://www.msss.gouv.qc.ca/professionnels/vaccination/piq-vaccins/zona-su-vaccin-sous-unitaire-contre-le-zona/</p><p>Immunocompromised patients often need multiple vaccinations - Please do your best to administer them in a single visit </p><p>•<strong>For adults and adolescents, COVID-19 vaccines may be given simultaneously with (i.e., same day), or at any time before or after, non-COVID-19 vaccines (including live and non-live vaccines)</strong>.</p><p> </p><p><strong>Despite strong uptake of COVID-19 vaccinations, other adult immunizations lag behind - Be sure to address all "Immunization Gaps" for your Clinically Vulnerable Patients </strong></p>
]]></content:encoded>
      <enclosure length="26449755" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/92eb2092-cbcd-48e0-ae43-93157051e959/audio/2073d295-a2ed-42bb-b151-c4b6ea533755/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Not compromising with vaccine preventable diseases</itunes:title>
      <itunes:author>Christine Palmay, Ajit Johal</itunes:author>
      <itunes:duration>00:27:33</itunes:duration>
      <itunes:summary>The literal definition of &quot;compromise&quot; means to &quot;accept standards that are lower than is desirable&quot;.  In clinical practice we far too often accept that our immunocompromised patients (be it medical or medication induced) will suffer disproportionately from vaccine preventable diseases.  Join Ajit and Christine in this informative podcast detailing how pharmacists and physicians can protect their immunocompromised patients against vaccine preventable diseases.  </itunes:summary>
      <itunes:subtitle>The literal definition of &quot;compromise&quot; means to &quot;accept standards that are lower than is desirable&quot;.  In clinical practice we far too often accept that our immunocompromised patients (be it medical or medication induced) will suffer disproportionately from vaccine preventable diseases.  Join Ajit and Christine in this informative podcast detailing how pharmacists and physicians can protect their immunocompromised patients against vaccine preventable diseases.  </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0f23b26f-2e7c-414d-a3f7-f675fcea6fef</guid>
      <title>Special Guest Dr. Paul Offit</title>
      <description><![CDATA[<p><i>About Dr. Paul Offit</i></p><p><a href="https://www.paul-offit.com/">Health Expert | Paul Offit MD official author site, Philadelphia, PA (paul-offit.com)</a></p><p><i>Dr. Offit's publications cited in this episode </i></p><p><a href="https://www.amazon.ca/Pandoras-Lab-Seven-Stories-Science/dp/1426217986/ref=pd_lpo_3?pd_rd_i=1426217986&psc=1">Pandora's Lab: Seven Stories of Science Gone Wrong: Offit M.D., Paul A.: 9781426217982: Books - Amazon.ca</a></p><p><a href="https://www.amazon.ca/You-Bet-Your-Life-Transfusions/dp/1541620399">You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation : Offit MD, Paul A: Books - Amazon</a></p>
]]></description>
      <pubDate>Mon, 16 May 2022 04:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (PHARMED)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/special-guest-dr-paul-offit-LRlIYjhw</link>
      <content:encoded><![CDATA[<p><i>About Dr. Paul Offit</i></p><p><a href="https://www.paul-offit.com/">Health Expert | Paul Offit MD official author site, Philadelphia, PA (paul-offit.com)</a></p><p><i>Dr. Offit's publications cited in this episode </i></p><p><a href="https://www.amazon.ca/Pandoras-Lab-Seven-Stories-Science/dp/1426217986/ref=pd_lpo_3?pd_rd_i=1426217986&psc=1">Pandora's Lab: Seven Stories of Science Gone Wrong: Offit M.D., Paul A.: 9781426217982: Books - Amazon.ca</a></p><p><a href="https://www.amazon.ca/You-Bet-Your-Life-Transfusions/dp/1541620399">You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation : Offit MD, Paul A: Books - Amazon</a></p>
]]></content:encoded>
      <enclosure length="104946012" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/ac42f35f-d7a8-4310-8bb1-8051ad2af54e/audio/ef485d28-c428-4dae-aee8-da7fdb7dd506/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Special Guest Dr. Paul Offit</itunes:title>
      <itunes:author>PHARMED</itunes:author>
      <itunes:duration>00:43:45</itunes:duration>
      <itunes:summary>In Episode 6 Ajit and Christine have a conversation with American pediatrician and renowned specialist  in infectious diseases, vaccines, immunology, and virology - Dr. Paul Offit.  Don&apos;t miss this engaging discussion on COVID-19, vaccine hesitancy, HPV vaccination and more!</itunes:summary>
      <itunes:subtitle>In Episode 6 Ajit and Christine have a conversation with American pediatrician and renowned specialist  in infectious diseases, vaccines, immunology, and virology - Dr. Paul Offit.  Don&apos;t miss this engaging discussion on COVID-19, vaccine hesitancy, HPV vaccination and more!</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">23a1dc30-2383-471d-85f0-91987530996d</guid>
      <title>New Guidance for Pneumococcal Vaccination</title>
      <description><![CDATA[<p>Thank you for Dr. Christine Palmay for putting together these comprehensive resources to comprise the Episode 5 show notes!</p><p> </p><p>Link to PDF with FULL Show NOTES - https://acrobat.adobe.com/link/review?uri=urn:aaid:scds:US:a32591bd-02d9-3534-ace5-11bd1da8c92f</p><p> </p><p>Summary and Links BELOW</p><p><strong>ACIP Meeting Materials:  </strong>There were 3 ACIP meetings where they reviewed PCV20.  The general topic and links are below.I have also attached the slides. </p><p> </p><p>Link: <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-2-24-25.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-2-24-25.html</a></p><p> </p><p>Link: <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-06.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-06.html</a></p><p> </p><p>Link:  <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-10-20-21.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-10-20-21.html</a></p><p> </p><p> </p><p><strong>Ontario Epidemiology for IPD:</strong></p><p> </p><p>Citation: Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL (2019) The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS ONE 14(12): e0226353. <a href="https://doi.org/10.1371/journal.pone.0226353" target="_blank">https://doi.org/10.1371/journal.pone.0226353</a></p><p> </p><p>Link: <a href="https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/reportable-disease-trends-annually#/52" target="_blank">https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/reportable-disease-trends-annually#/52</a></p><p> </p><p><strong>National Reportable Disease – Pre-built epidemiology graphs:</strong>  <a href="https://diseases.canada.ca/notifiable/charts-pre-built" target="_blank">Notifiable disease pre-built charts - Notifiable diseases on-line (canada.ca)</a></p>
]]></description>
      <pubDate>Sun, 1 May 2022 04:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (Christine Palmay)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/new-guidance-for-pneumococcal-vaccination-JefK7MeY</link>
      <content:encoded><![CDATA[<p>Thank you for Dr. Christine Palmay for putting together these comprehensive resources to comprise the Episode 5 show notes!</p><p> </p><p>Link to PDF with FULL Show NOTES - https://acrobat.adobe.com/link/review?uri=urn:aaid:scds:US:a32591bd-02d9-3534-ace5-11bd1da8c92f</p><p> </p><p>Summary and Links BELOW</p><p><strong>ACIP Meeting Materials:  </strong>There were 3 ACIP meetings where they reviewed PCV20.  The general topic and links are below.I have also attached the slides. </p><p> </p><p>Link: <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-2-24-25.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-2-24-25.html</a></p><p> </p><p>Link: <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-06.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-06.html</a></p><p> </p><p>Link:  <a href="https://www.cdc.gov/vaccines/acip/meetings/slides-2021-10-20-21.html" target="_blank">https://www.cdc.gov/vaccines/acip/meetings/slides-2021-10-20-21.html</a></p><p> </p><p> </p><p><strong>Ontario Epidemiology for IPD:</strong></p><p> </p><p>Citation: Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL (2019) The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS ONE 14(12): e0226353. <a href="https://doi.org/10.1371/journal.pone.0226353" target="_blank">https://doi.org/10.1371/journal.pone.0226353</a></p><p> </p><p>Link: <a href="https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/reportable-disease-trends-annually#/52" target="_blank">https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/reportable-disease-trends-annually#/52</a></p><p> </p><p><strong>National Reportable Disease – Pre-built epidemiology graphs:</strong>  <a href="https://diseases.canada.ca/notifiable/charts-pre-built" target="_blank">Notifiable disease pre-built charts - Notifiable diseases on-line (canada.ca)</a></p>
]]></content:encoded>
      <enclosure length="83218284" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/7e60e8e2-71c6-447c-9973-d7446fda468b/audio/58ee8685-8c7a-4553-bb00-e63f22c01b57/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>New Guidance for Pneumococcal Vaccination</itunes:title>
      <itunes:author>Christine Palmay</itunes:author>
      <itunes:duration>00:34:42</itunes:duration>
      <itunes:summary>In Episode 5 - Ajit and Christine discuss the recent ACIP meetings on novel conjugate pneumococcal vaccinations PCV15 and PCV20.  Focusing on the importance of protecting patients against pneumococcal disease, the burden of community vs invasive disease and understanding the differential immune response from polysaccharide vs conjugate options.  A must listen for frontline immunization providers who want to stay up to date and ensure their patients are protected as best as possible! </itunes:summary>
      <itunes:subtitle>In Episode 5 - Ajit and Christine discuss the recent ACIP meetings on novel conjugate pneumococcal vaccinations PCV15 and PCV20.  Focusing on the importance of protecting patients against pneumococcal disease, the burden of community vs invasive disease and understanding the differential immune response from polysaccharide vs conjugate options.  A must listen for frontline immunization providers who want to stay up to date and ensure their patients are protected as best as possible! </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6f3b0be4-aed9-430a-9409-a83f2d515f3a</guid>
      <title>Episode 4- Focusing on the “Y” in HPV-related cancer Prevention</title>
      <description><![CDATA[In Episode 4, Ajit and Christine discuss the importance of the HPV vaccination as a “gender neutral vaccine”.  Males are at risk for persistent HPV infection and devastating morbidity from HPV-related cancers.  Front-line health care providers such as pharmacists and physicians play a critical role in addressing the gender misconceptions of the HPV vaccine.  This episode provides practical tips in identifying opportunities to protect them against a preventable cancer risk.  ]]></description>
      <pubDate>Wed, 2 Feb 2022 05:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (PHARMED)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/episode-4-focusing-on-the-y-in-hpv-related-cancer-prevention-KE3UBsEM</link>
      <enclosure length="28664102" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/1a293a5f-ab8f-40e5-b301-e468732cfb31/audio/b178a538-b9a7-4098-b174-938e902c05ce/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Episode 4- Focusing on the “Y” in HPV-related cancer Prevention</itunes:title>
      <itunes:author>PHARMED</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/b510a02d-6257-4d75-9109-5d57fdc34339/8b458ecc-72d5-4afa-bd4c-deec46fd65bc/3000x3000/printable-resolution-option2-01.jpg?aid=rss_feed"/>
      <itunes:duration>00:29:51</itunes:duration>
      <itunes:summary>In Episode 4, Ajit and Christine discuss the importance of the HPV vaccination as a “gender neutral vaccine”.  Males are at risk for persistent HPV infection and devastating morbidity from HPV-related cancers.  Front-line health care providers such as pharmacists and physicians play a critical role in addressing the gender misconceptions of the HPV vaccine.  This episode provides practical tips in identifying opportunities to protect them against a preventable cancer risk.  </itunes:summary>
      <itunes:subtitle>In Episode 4, Ajit and Christine discuss the importance of the HPV vaccination as a “gender neutral vaccine”.  Males are at risk for persistent HPV infection and devastating morbidity from HPV-related cancers.  Front-line health care providers such as pharmacists and physicians play a critical role in addressing the gender misconceptions of the HPV vaccine.  This episode provides practical tips in identifying opportunities to protect them against a preventable cancer risk.  </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e0874fdd-3fd4-488a-bd78-4ab92a1451ef</guid>
      <title>Episode 3 &quot;Vintage Vaccines&quot;</title>
      <description><![CDATA[In Episode 3 Ajit and Christine switch age demographics to highlight the vaccination needs for "vintage" adults.  With age comes quality, experience, and an increased risk of reactivation of dormant HZV!   Don't miss this episode where we discuss the importance of shingles vaccination in your at risk patient population.   ]]></description>
      <pubDate>Fri, 31 Dec 2021 05:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (PHARMED)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/episode-3-vintage-vaccines-8E4M1Flw</link>
      <enclosure length="27819825" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/25744155-22e5-4d4f-9e5a-4b9ddcf3ab97/audio/911f5c85-37f0-4de8-9097-ea904acd98d0/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Episode 3 &quot;Vintage Vaccines&quot;</itunes:title>
      <itunes:author>PHARMED</itunes:author>
      <itunes:duration>00:28:59</itunes:duration>
      <itunes:summary>In Episode 3 Ajit and Christine switch age demographics to highlight the vaccination needs for &quot;vintage&quot; adults.  With age comes quality, experience, and an increased risk of reactivation of dormant HZV!   Don&apos;t miss this episode where we discuss the importance of shingles vaccination in your at risk patient population.   </itunes:summary>
      <itunes:subtitle>In Episode 3 Ajit and Christine switch age demographics to highlight the vaccination needs for &quot;vintage&quot; adults.  With age comes quality, experience, and an increased risk of reactivation of dormant HZV!   Don&apos;t miss this episode where we discuss the importance of shingles vaccination in your at risk patient population.   </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6d322157-c0fd-4d82-8d0d-49fe7e264131</guid>
      <title>Episode 2: &quot;QuaranTEENS&quot;</title>
      <description><![CDATA[<p><i><strong>Episode 2 Resources</strong></i></p><p><i><strong>Lockdown Life: Mental Health impacts of COVID-19 on youth in Canada </strong></i></p><p>The survey provides an overview of how youth from different regions are generally doing during the pandemic. The survey questions were focused on the challenges they faced, the strategies they used for coping, the help-seeking behaviours they engaged in to support their mental health and any positive experiences they had during this period of uncertainty. The survey also examined the communication methods youth used to stay connected with others and to find information on protection against COVID-19.</p><p><strong>Reference: </strong><a href="https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:854989bb-cb2a-40fc-8bcd-d6778cbe541c">https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:854989bb-cb2a-40fc-8bcd-d6778cbe541c</a></p><p><i><strong>Finnish study of HPV infection at birth (Evidence of non-sexual transmission)</strong></i></p><p>This study indicates that HPV infection can be acquired nonsexually and is already common at an early age (22.9% of the oral samples collected immediately after birth were positive for HPV DNA). </p><p><strong>Reference:</strong></p><p>Syrjänen, S., Rintala, M., Sarkola, M., Willberg, J., Rautava, J., Koskimaa, H....Louvanto, K. (2021). Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland. <i>Emerging Infectious Diseases</i>, <i>27</i>(3), 759-766. https://dx.doi.org/10.3201/eid2703.202721</p><p><i><strong>B for Kai</strong></i></p><p>Following the Tragic and Preventable death of 19-year-old Kai Matthews in the summer of 2021 from invasive meningitis B infection- the following website was established. </p><p><strong>Reference</strong></p><p><a href="https://bforkai.com/">B for Kai – Join us in our fight against meningitis B</a></p><p> </p><p><i><strong>Long-term effects on academic performance for survivors of Invasive Meningococcal Disease (IMD)</strong></i></p><p>Adolescent IMD survivors and case-matched controls (n=105 and 107, respectively) were followed from September 2000 to July 2002, 18 to 36 months after disease, to evaluate the long-term outcomes of IMD on their overall quality of life, reduced physical ability (including injury, disability, or fatigue), depression, stress, educational achievements, cognitive function, social relationships, or need for subsequent medical care.</p><p><i>Individuals who contracted IMD at 15–19 years of age were shown to have significantly lower quality of life, higher total and mental fatigue scores, and poorer educational achievements than age-matched controls, demonstrating the long-term impact of IMD on this age group.</i></p><p><strong>Reference</strong></p><p>Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, match-cohort study. <i>Pediatrics</i>. 2009;123(3):e502-e509.</p><p> </p><p><strong>MenB Risk on college campuses</strong></p><p>While 10% of the general population consists of meningococcal carriers1, the rate of carriage increases to up to 24% in adolescents and young adults2, and can be as high as 50% in adolescents or young adults in crowded settings.1</p><p><strong>References</strong></p><p>Christensen et all. Meningococcal carriage by age: a systematic review and meta-analysis: Lancet Infect Dis. 2010;10(12):853-861 </p><p><strong>Teen Talk Time Resource </strong></p><p>Created by Dr. Christine Palmay – an incredibly useful resource for “optimizing” a youth healthcare visit</p><p><strong>Reference:</strong></p><p><a href="https://documentcloud.adobe.com/link/track?uri=urn:aaid:scds:US:0aaa9463-de7d-4f85-b591-680bfc603957">https://documentcloud.adobe.com/link/track?uri=urn:aaid:scds:US:0aaa9463-de7d-4f85-b591-680bfc603957</a></p>
]]></description>
      <pubDate>Mon, 25 Oct 2021 23:00:00 +0000</pubDate>
      <author>ajit@travelrx.ca (Christine Palmay, Ajit Johal)</author>
      <link>https://the-pharmed-podcast.simplecast.com/episodes/episode-2-quaranteens-APReVe3m</link>
      <content:encoded><![CDATA[<p><i><strong>Episode 2 Resources</strong></i></p><p><i><strong>Lockdown Life: Mental Health impacts of COVID-19 on youth in Canada </strong></i></p><p>The survey provides an overview of how youth from different regions are generally doing during the pandemic. The survey questions were focused on the challenges they faced, the strategies they used for coping, the help-seeking behaviours they engaged in to support their mental health and any positive experiences they had during this period of uncertainty. The survey also examined the communication methods youth used to stay connected with others and to find information on protection against COVID-19.</p><p><strong>Reference: </strong><a href="https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:854989bb-cb2a-40fc-8bcd-d6778cbe541c">https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:854989bb-cb2a-40fc-8bcd-d6778cbe541c</a></p><p><i><strong>Finnish study of HPV infection at birth (Evidence of non-sexual transmission)</strong></i></p><p>This study indicates that HPV infection can be acquired nonsexually and is already common at an early age (22.9% of the oral samples collected immediately after birth were positive for HPV DNA). </p><p><strong>Reference:</strong></p><p>Syrjänen, S., Rintala, M., Sarkola, M., Willberg, J., Rautava, J., Koskimaa, H....Louvanto, K. (2021). Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland. <i>Emerging Infectious Diseases</i>, <i>27</i>(3), 759-766. https://dx.doi.org/10.3201/eid2703.202721</p><p><i><strong>B for Kai</strong></i></p><p>Following the Tragic and Preventable death of 19-year-old Kai Matthews in the summer of 2021 from invasive meningitis B infection- the following website was established. </p><p><strong>Reference</strong></p><p><a href="https://bforkai.com/">B for Kai – Join us in our fight against meningitis B</a></p><p> </p><p><i><strong>Long-term effects on academic performance for survivors of Invasive Meningococcal Disease (IMD)</strong></i></p><p>Adolescent IMD survivors and case-matched controls (n=105 and 107, respectively) were followed from September 2000 to July 2002, 18 to 36 months after disease, to evaluate the long-term outcomes of IMD on their overall quality of life, reduced physical ability (including injury, disability, or fatigue), depression, stress, educational achievements, cognitive function, social relationships, or need for subsequent medical care.</p><p><i>Individuals who contracted IMD at 15–19 years of age were shown to have significantly lower quality of life, higher total and mental fatigue scores, and poorer educational achievements than age-matched controls, demonstrating the long-term impact of IMD on this age group.</i></p><p><strong>Reference</strong></p><p>Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, match-cohort study. <i>Pediatrics</i>. 2009;123(3):e502-e509.</p><p> </p><p><strong>MenB Risk on college campuses</strong></p><p>While 10% of the general population consists of meningococcal carriers1, the rate of carriage increases to up to 24% in adolescents and young adults2, and can be as high as 50% in adolescents or young adults in crowded settings.1</p><p><strong>References</strong></p><p>Christensen et all. Meningococcal carriage by age: a systematic review and meta-analysis: Lancet Infect Dis. 2010;10(12):853-861 </p><p><strong>Teen Talk Time Resource </strong></p><p>Created by Dr. Christine Palmay – an incredibly useful resource for “optimizing” a youth healthcare visit</p><p><strong>Reference:</strong></p><p><a href="https://documentcloud.adobe.com/link/track?uri=urn:aaid:scds:US:0aaa9463-de7d-4f85-b591-680bfc603957">https://documentcloud.adobe.com/link/track?uri=urn:aaid:scds:US:0aaa9463-de7d-4f85-b591-680bfc603957</a></p>
]]></content:encoded>
      <enclosure length="42055933" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/85ec2ba8-60e4-4051-80e1-a05dfbe30534/audio/a69a293f-63da-488a-8572-a541f4ffb592/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Episode 2: &quot;QuaranTEENS&quot;</itunes:title>
      <itunes:author>Christine Palmay, Ajit Johal</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/b510a02d-6257-4d75-9109-5d57fdc34339/94e0758f-f135-4a2d-b5e3-2c59a675be0b/3000x3000/logo-transparency-option2-01.jpg?aid=rss_feed"/>
      <itunes:duration>00:43:48</itunes:duration>
      <itunes:summary>The COVID-19 &quot;Lockdown Life&quot; has been a struggle for all of us, especially Canadian youth.  In Episode 2 of the Pharmed podcast Ajit and Christine talk about collaborative approaches to improve the health and well being of adolescent patients.  Age and risk specific vaccinations are powerful and accessible tools that can be leveraged to protect our youth against the devastation of preventable diseases.   </itunes:summary>
      <itunes:subtitle>The COVID-19 &quot;Lockdown Life&quot; has been a struggle for all of us, especially Canadian youth.  In Episode 2 of the Pharmed podcast Ajit and Christine talk about collaborative approaches to improve the health and well being of adolescent patients.  Age and risk specific vaccinations are powerful and accessible tools that can be leveraged to protect our youth against the devastation of preventable diseases.   </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ca6e8cb-b417-4448-97cf-62fceeb22aa2</guid>
      <title>Resilience in Healthcare</title>
      <description><![CDATA[<p>RESOURCES:</p><p> </p><p><strong>1.     UofT Modules – excellent updated resources, particularly helpful in-depth vaccine summary:</strong></p><p><a href="https://www.dfcm.utoronto.ca/covid19-vaccination-modules?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+%E2%80%93+Next+Iteration&utm_term=https%3a%2f%2fwww.dfcm.utoronto.ca%2fcovid19-vaccination-modules&utm_id=153759&sfmc_id=7575660" target="_blank">https://www.dfcm.utoronto.ca/covid19-vaccination-modules?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+–+Next+Iteration&utm_term=https%3a%2f%2fwww.dfcm.utoronto.ca%2fcovid19-vaccination-modules&utm_id=153759&sfmc_id=7575660</a></p><p> </p><p><strong>2.     University of Calgary Vaccine Hesitency Tool</strong></p><p><a href="https://www.vhguide.ca/" target="_blank"><strong>https://www.vhguide.ca</strong></a></p><p> </p><p><strong>3.     Centre for Effective Practice – Updated Information</strong></p><p><a href="https://cep.health/toolkit/covid-19-resource-centre/" target="_blank">https://cep.health/toolkit/covid-19-resource-centre/</a></p><p> 4.  <strong>Government of Canada –</strong></p><p><a href="https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+%E2%80%93+Next+Iteration&utm_term=https%3a%2f%2fwww.canada.ca%2fen%2fpublic-health%2fservices%2fdiseases%2fcoronavirus-disease-covid-19%2fvaccines.html&utm_id=153759&sfmc_id=7575660" target="_blank">https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+–+Next+Iteration&utm_term=https%3a%2f%2fwww.canada.ca%2fen%2fpublic-health%2fservices%2fdiseases%2fcoronavirus-disease-covid-19%2fvaccines.html&utm_id=153759&sfmc_id=7575660</a></p>
]]></description>
      <pubDate>Wed, 22 Sep 2021 01:27:27 +0000</pubDate>
      <author>ajit@travelrx.ca (PHARMED)</author>
      <link>https://immunize.io/</link>
      <content:encoded><![CDATA[<p>RESOURCES:</p><p> </p><p><strong>1.     UofT Modules – excellent updated resources, particularly helpful in-depth vaccine summary:</strong></p><p><a href="https://www.dfcm.utoronto.ca/covid19-vaccination-modules?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+%E2%80%93+Next+Iteration&utm_term=https%3a%2f%2fwww.dfcm.utoronto.ca%2fcovid19-vaccination-modules&utm_id=153759&sfmc_id=7575660" target="_blank">https://www.dfcm.utoronto.ca/covid19-vaccination-modules?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+–+Next+Iteration&utm_term=https%3a%2f%2fwww.dfcm.utoronto.ca%2fcovid19-vaccination-modules&utm_id=153759&sfmc_id=7575660</a></p><p> </p><p><strong>2.     University of Calgary Vaccine Hesitency Tool</strong></p><p><a href="https://www.vhguide.ca/" target="_blank"><strong>https://www.vhguide.ca</strong></a></p><p> </p><p><strong>3.     Centre for Effective Practice – Updated Information</strong></p><p><a href="https://cep.health/toolkit/covid-19-resource-centre/" target="_blank">https://cep.health/toolkit/covid-19-resource-centre/</a></p><p> 4.  <strong>Government of Canada –</strong></p><p><a href="https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+%E2%80%93+Next+Iteration&utm_term=https%3a%2f%2fwww.canada.ca%2fen%2fpublic-health%2fservices%2fdiseases%2fcoronavirus-disease-covid-19%2fvaccines.html&utm_id=153759&sfmc_id=7575660" target="_blank">https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?utm_source=sfmc&utm_medium=email&utm_campaign=SGFP+Aggregate+Primary+Care+Vaccination+Report+–+Next+Iteration&utm_term=https%3a%2f%2fwww.canada.ca%2fen%2fpublic-health%2fservices%2fdiseases%2fcoronavirus-disease-covid-19%2fvaccines.html&utm_id=153759&sfmc_id=7575660</a></p>
]]></content:encoded>
      <enclosure length="63542796" type="audio/mpeg" url="https://cdn.simplecast.com/audio/eeddf9a4-865b-4b5e-84b1-2e9e0242add9/episodes/60c74171-ac27-4c78-9f6a-bdc48398f363/audio/bca7d17d-e963-4e3f-be66-ee9568adc9b6/default_tc.mp3?aid=rss_feed&amp;feed=6cwg4X41"/>
      <itunes:title>Resilience in Healthcare</itunes:title>
      <itunes:author>PHARMED</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/b510a02d-6257-4d75-9109-5d57fdc34339/010463de-b305-48a5-bd8f-3cf88ecc793f/3000x3000/printable-resolution-option2-01.jpg?aid=rss_feed"/>
      <itunes:duration>01:06:11</itunes:duration>
      <itunes:summary>In the inaugural episode Ajit and Christine discuss the current climate faced by both pharmacists and physicians.  In the midst of the ongoing pandemic vaccinations remain a clear priority.  This includes the upcoming influenza season, vaccine hesitancy, and opportunities for collaboration. </itunes:summary>
      <itunes:subtitle>In the inaugural episode Ajit and Christine discuss the current climate faced by both pharmacists and physicians.  In the midst of the ongoing pandemic vaccinations remain a clear priority.  This includes the upcoming influenza season, vaccine hesitancy, and opportunities for collaboration. </itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
  </channel>
</rss>